[Differentiated therapy in Crohn's disease].

Area of Science:

• Gastroenterology
• Immunology
• Pharmacology

Context:

• Crohn's disease, a chronic inflammatory bowel condition, presents complex therapeutic challenges due to its unknown etiology.
• Current management focuses on symptomatic relief and complication control rather than a causal cure.
• Established treatments include adrenocorticoids and sulfasalazine, supported by adjunctive therapies during acute phases.

Purpose:

• To review the current therapeutic landscape for Crohn's disease, emphasizing established treatments and surgical indications.
• To highlight the limitations in causal therapy and the importance of individualized treatment strategies.
• To provide guidance on managing acute attacks and the role of surgery in Crohn's disease management.

Summary:

• Causal therapy for Crohn's disease remains elusive due to its unknown origins.
• Randomized trials confirm adrenocorticoids and sulfasalazine as the most effective foundational therapies.
• Supportive measures like hyperalimentation and vitamin substitution are vital during acute exacerbations.
• Maintenance therapy is generally not recommended; approximately 60% of patients require surgery for disease complications.
• Surgical decision-making is guided by clear indications, and treatment must be adapted to disease severity and location.

Impact:

• This review clarifies current best practices in Crohn's disease management, optimizing patient outcomes.
• Understanding surgical indications can lead to more timely and appropriate interventions, reducing morbidity.
• Differentiating therapy based on disease characteristics allows for personalized treatment plans, improving quality of life.